EUVIMEDEUVIMED entdecken
Open Access

R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25

Paul Arora, Sreeram V Ramagopalan

Journal of Comparative Effectiveness Research · 2026-06 · 15 (6)

DOI: 10.57264/cer-2026-0073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2026-06. Verfasst von Paul Arora und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this update, we discuss the use of real-world data in the Haute Autorité de Santé assessment of economic evaluations, review how real-world evidence is supporting regulatory approvals in multiple myeloma, and consider lessons from the failed EVOKE trials of semaglutide in Alzheimer's disease for the broader application of target trial emulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalHumansAlzheimer DiseaseSemaglutideMultiple MyelomaGlucagon-Like PeptidesCost-Benefit AnalysisCost-Effectiveness Analysis

Stichwörter der Autor:innen

Alzheimer's diseaseEVOKE trialsGLP-1Haute Autorité de Santéhealth technology assessmentmultiple myelomaneurologyoncologyreal-world datareal-world evidencetarget trial emulation

Substanzen

SemaglutideGlucagon-Like Peptides

Autor:innen und Institutionen

  • Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.
  • Inka Health, 100 King St W. Suite 1600. Toronto, ON M5X 1G5, Canada.
  • Centre for Pharmaceutical Medicine Research, King's College London, London, SE1 9NH, UK.

Zitieren

APA

Arora, P., & Ramagopalan, S. V. (2026). R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25. Journal of Comparative Effectiveness Research, 15(6). https://doi.org/10.57264/cer-2026-0073

Vancouver

Arora P, Ramagopalan SV. R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25. Journal of Comparative Effectiveness Research. 2026;15(6). doi:10.57264/cer-2026-0073

BibTeX
@article{Arora2026,
  author = {Arora, Paul and Ramagopalan, Sreeram V},
  title = {R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.57264/cer-2026-0073}
}
Kostenlos starten →